Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 176 | Chinese Journal of Cancer Biotherapy | journal | 0.100 Q4 | 5 | 122 | 243 | 2977 | 3 | 240 | 0.01 | 24.40 |  |
| 175 | Sp2 | trade journal | 0.100 Q4 | 2 | 51 | 146 | 29 | 0 | 130 | 0.00 | 0.57 |  |
| 174 | Frontiers in Medicinal Chemistry | book series | 0.101 Q4 | 7 | 0 | 32 | 0 | 1 | 14 | 0.06 | 0.00 |  |
| 173 | VacciMonitor | journal | 0.101 Q4 | 5 | 24 | 22 | 451 | 0 | 21 | 0.00 | 18.79 |  |
| 172 | IEEE International Conference on Nano/Molecular Medicine and Engineering, NANOMED | conference and proceedings | 0.102 | 5 | 29 | 29 | 425 | 1 | 27 | 0.03 | 14.66 |  |
| 171 | Drugs in Context | journal | 0.107 Q4 | 36 | 13 | 3 | 461 | 0 | 3 | 0.00 | 35.46 | |
| 170 | Current Biomarkers | journal | 0.108 Q4 | 3 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 169 | Methods in Pharmacology and Toxicology | book series | 0.112 Q4 | 14 | 0 | 44 | 0 | 7 | 41 | 0.16 | 0.00 | |
| 168 | 2010 IEEE International Conference on Nano/Molecular Medicine and Engineering, IEEE NANOMED 2010 | conference and proceedings | 0.119 | 5 | 0 | 53 | 0 | 10 | 50 | 0.00 | 0.00 | |
| 167 | Gene Therapy and Molecular Biology | journal | 0.121 Q4 | 18 | 18 | 12 | 644 | 3 | 12 | 0.25 | 35.78 |  |
| 166 | Journal of Experimental Pharmacology | journal | 0.129 Q4 | 23 | 1 | 3 | 166 | 2 | 3 | 0.50 | 166.00 |  |
| 165 | Gene Therapy and Regulation | journal | 0.131 Q4 | 7 | 0 | 17 | 0 | 6 | 15 | 0.45 | 0.00 |  |
| 164 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.134 Q4 | 16 | 40 | 162 | 1707 | 47 | 162 | 0.23 | 42.68 | |
| 163 | Open Pharmacology Journal | journal | 0.139 Q4 | 6 | 4 | 10 | 130 | 7 | 10 | 0.33 | 32.50 | |
| 162 | Cellular Therapy and Transplantation | journal | 0.163 Q4 | 8 | 0 | 36 | 0 | 10 | 35 | 0.10 | 0.00 |  |
| 161 | Nucleus (India) | journal | 0.164 Q4 | 17 | 25 | 31 | 808 | 11 | 30 | 0.35 | 32.32 |  |
| 160 | European Pharmaceutical Review | trade journal | 0.166 Q4 | 9 | 64 | 122 | 986 | 26 | 120 | 0.30 | 15.41 | |
| 159 | Open Bioactive Compounds Journal | journal | 0.172 Q4 | 6 | 4 | 3 | 123 | 4 | 3 | 0.00 | 30.75 | |
| 158 | EXCLI Journal | journal | 0.199 Q4 | 55 | 95 | 145 | 3855 | 120 | 124 | 0.81 | 40.58 | |
| 157 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.199 Q4 | 29 | 12 | 34 | 1144 | 19 | 0 | 0.58 | 95.33 | |
| 156 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.206 Q4 | 14 | 16 | 85 | 1044 | 27 | 78 | 0.33 | 65.25 | |
| 155 | Journal of Biological Sciences (discontinued) | journal | 0.215 Q4 | 38 | 99 | 233 | 3673 | 163 | 233 | 0.54 | 37.10 |  |
| 154 | Journal of Stem Cells | journal | 0.224 Q4 | 21 | 14 | 58 | 1245 | 32 | 58 | 0.40 | 88.93 | |
| 153 | Current Enzyme Inhibition | journal | 0.231 Q4 | 19 | 18 | 60 | 1416 | 41 | 55 | 0.51 | 78.67 |  |
| 152 | Turkish Journal of Pharmaceutical Sciences | journal | 0.231 Q4 | 22 | 42 | 85 | 1194 | 44 | 85 | 0.53 | 28.43 |  |
| 151 | Yaoxue Xuebao | journal | 0.231 Q4 | 36 | 272 | 773 | 7039 | 517 | 773 | 0.68 | 25.88 | |
| 150 | Current Cancer Therapy Reviews | journal | 0.236 Q4 | 17 | 26 | 101 | 2513 | 49 | 95 | 0.43 | 96.65 | |
| 149 | Current Pharmacogenomics and Personalized Medicine | journal | 0.262 Q4 | 20 | 38 | 103 | 1871 | 117 | 80 | 1.28 | 49.24 | |
| 148 | Pteridines | journal | 0.271 Q4 | 19 | 32 | 31 | 1342 | 24 | 31 | 0.90 | 41.94 | |
| 147 | Biomolecules and Therapeutics | journal | 0.272 Q4 | 56 | 70 | 211 | 2808 | 184 | 211 | 0.92 | 40.11 |  |
| 146 | Expert Opinion on Medical Diagnostics | journal | 0.273 Q4 | 28 | 60 | 144 | 4380 | 154 | 141 | 1.11 | 73.00 | |
| 145 | Drug Discovery Today: Disease Models | journal | 0.288 Q4 | 33 | 34 | 76 | 1646 | 53 | 67 | 0.70 | 48.41 | |
| 144 | Current Pharmaceutical Analysis | journal | 0.294 Q4 | 27 | 44 | 108 | 1755 | 117 | 107 | 0.80 | 39.89 | |
| 143 | Letters in Drug Design and Discovery | journal | 0.294 Q4 | 37 | 131 | 375 | 3537 | 410 | 371 | 0.97 | 27.00 | |
| 142 | International Journal of Peptide Research and Therapeutics | journal | 0.302 Q4 | 45 | 44 | 117 | 1394 | 122 | 116 | 0.80 | 31.68 | |
| 141 | MCB Molecular and Cellular Biomechanics | journal | 0.326 Q4 | 31 | 16 | 52 | 553 | 47 | 52 | 0.91 | 34.56 | |
| 140 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.352 Q4 | 53 | 48 | 280 | 1434 | 303 | 280 | 1.07 | 29.88 | |
| 139 | Virologica Sinica | journal | 0.354 Q4 | 47 | 52 | 149 | 1665 | 150 | 145 | 1.14 | 32.02 | |
| 138 | Topics in Medicinal Chemistry | book series | 0.366 Q4 | 15 | 0 | 32 | 0 | 18 | 24 | 0.94 | 0.00 | |
| 137 | Personalized Medicine | journal | 0.392 Q4 | 36 | 93 | 271 | 3420 | 289 | 214 | 0.98 | 36.77 | |
| 136 | Genetic Vaccines and Therapy | journal | 0.421 Q4 | 30 | 0 | 32 | 0 | 46 | 32 | 1.21 | 0.00 | |
| 135 | Journal of Asian Natural Products Research | journal | 0.442 Q4 | 51 | 171 | 504 | 3457 | 624 | 503 | 1.17 | 20.22 | |
| 134 | Drug Discovery Today: Therapeutic Strategies | journal | 0.453 Q3 | 31 | 22 | 62 | 1225 | 87 | 55 | 1.58 | 55.68 | |
| 133 | Probiotics and Antimicrobial Proteins | journal | 0.458 Q3 | 52 | 30 | 90 | 1282 | 117 | 89 | 1.12 | 42.73 | |
| 132 | Biotechnology and Applied Biochemistry | journal | 0.464 Q3 | 81 | 72 | 178 | 3206 | 337 | 175 | 1.65 | 44.53 | |
| 131 | SAR and QSAR in Environmental Research | journal | 0.471 Q3 | 54 | 58 | 124 | 2516 | 268 | 123 | 2.16 | 43.38 | |
| 130 | Pharmaceutical Biology | journal | 0.493 Q3 | 88 | 213 | 591 | 7772 | 1017 | 591 | 1.72 | 36.49 | |
| 129 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.495 Q3 | 45 | 26 | 75 | 2332 | 108 | 69 | 1.10 | 89.69 | |
| 128 | Current Computer-Aided Drug Design | journal | 0.511 Q3 | 32 | 52 | 84 | 3394 | 162 | 76 | 1.77 | 65.27 | |
| 127 | Journal of Biochemical and Molecular Toxicology | journal | 0.529 Q3 | 69 | 63 | 165 | 2668 | 263 | 164 | 1.46 | 42.35 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data